10.0604.46% ( -0.470 )
Delay Closed: Nov 20, 16:08:14Valuation
Current ValuationThe current P/E ratio is 11.72, within the reasonable range, cheaper than 21.81% of the time in the past 3 years, and the industry ranks 10/78, the industry Median -4.64.
11.72xP/E
HK$10.53Stock price
HK$0.90Earnings per share
11.72xP/E
Stock priceHK$10.53Earnings per shareHK$0.90
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -19.71x
- Typical range
- -85.33x–13.40x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0145290435580
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
09995HKREMEGEN | 4.49x | 512.28% | HK$34.15B |
01530HK3SBIO | 3.48x | 71.09% | HK$33.16B |
09969HKINNOCARE | 11.72x | 13.45% | HK$18.61B |
02142HKHBM HOLDINGS-B | 12.94x | 8.46% | HK$8.57B |
01167HKJACOBIO-B | 5.48x | -- | HK$3.24B |
02509HKQYUNS-B | 4.96x | 23.95% | HK$3.12B |
06998HKEDDING GENOR | 12.31x | -- | HK$3.10B |
02197HKCLOVER BIO-B | 1.99x | -- | HK$1.95B |
01061HKESSEX BIO-TECH | 4.03x | 1.60% | HK$1.07B |
02566HKJIUYUAN GENE | 6.02x | -- | HK$966.88M |
00690HKUNI-BIO GROUP | 7.63x | -- | HK$370.22M |
08158HKCRMI | 2.59x | -- | HK$71.20M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
